Overview

Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This is a prospective, multi-center, randomized, pilot study comparing the WATCHMAN left atrial appendage occlusion device with Rivaroxaban therapy in patients with non-valvular atrial fibrillation.

Phase:

Phase 4

Details

Lead Sponsor:

Shulin Wu

Collaborators:

Beijing Anzhen Hospital
First Affiliated Hospital of Jinan University
First Affiliated Hospital, Sun Yat-Sen University
Guangdong Medical College
Nanfang Hospital of Southern Medical University
Second Affiliated Hospital of Guangzhou Medical University
The First Affiliated Hospital of Guangzhou Medical University
Wuhan Asia Heart Hospital

Treatments:

Anticoagulants
Rivaroxaban